Schedule a Donation
Volunteer
Give a Gift
Donate
What Can I Donate?
Whole Blood
Double Red Cell
Plasma
Platelets
Cord Blood
Funding for our Mission
What Do I Need to Know?
Frequently Asked Questions
Eligibility
Identification Requirements
Special Considerations
What Happens to My Blood?
Ways to Donate
Schedule Online
Donor Center Locations
Mobile Blood Drives
Mobile Apheresis Donation
Organize a Blood Drive
Email & Text Reminders
Financial Donations
Volunteer Opportunities
Products & Services
Products & Services
Blood Components
Ordering Blood Components
Online Reports/Status
Handling Storage and Returns
Apheresis and Cellular Therapies
Laboratory Testing
Cord Blood
Biological Products for Research
Transfusion Services
Transfusion Medicine
Transfusion Guide: Blood Components
Transfusion Safety/Administration
Online Reports/Status
Perinatal Testing
WA Center for Bleeding Disorders
WA Center for Bleeding Disorders Overview
For Physicians
Hospital Pharmacy – Factor Ordering
Patients
Patient Services
Patient Services Overview
Therapeutic Phlebotomy
Patient Services Physicians
Bleeding Disorders
WA Center for Bleeding Disorders
What Are Bleeding Disorders
For Patients
Ordering Factor
Transfusions
When You Need a Transfusion
Labs
Labs
Compatibility Testing Laboratory
Donor Testing-Quality Control Laboratory
Genomics Testing Laboratory
Hemostasis Reference Laboratory
Immunogenetics/HLA Laboratory
Platelet Immunology Laboratory
Immunohematology Reference Laboratory (IRL)
Lab Services
Clinical Trials & Contract Testing
Physician Consulting
Blood Components
Frequently Asked Questions
Lab Contacts
Lab Tests
Lab Test Index
Online Reports/Status
Research
Bloodworks Research Institute
Research Overview
Life Saving Discoveries
Now and in the Future
Strategic Plan
FCOI Compliance
Biological Products
Center for Global Impact
Core Facilities and Technologies
Core Overview
Biostatistics Core
Flow Cytometry Lab
Mass Spectrometry Lab
Researchers
Meet Our Researchers
Jing-Fei Dong M.D., Ph.D.
Xiaoyun Fu, Ph.D.
Dominic Chung Ph.D.
Krystalyn E Hudson, Ph.D.
Jill M. Johnsen, M.D.
Barbara A. Konkle, M.D.
José López, M.D.
Karen Nelson, Ph.D. D (ABHI)
Sherrill Slichter, M.D.
Paul Warner, Ph.D.
James Zimring, M.D., Ph.D.
About Us
Who We Are
About Us
Leadership Team
Board of Trustees
Careers
Licenses and Accreditations
Medical staff
James AuBuchon, M.D.
Meghan Delaney, D.O., M.P.H.
Rebecca Haley, M.D.
Barbara Konkle, M.D.
Theresa A. Nester, M.D.
Yanyun Wu, M.D.
Kirsten Alcorn, M.D.
Rebecca Kruse-Jarres, MD, MPH
Our Impact
Lives Saved
Awards and Recognitions
2016 Community Report
News & Community Events
Center for Global Impact | Bloodpak
Education & Training
Introduction to Hematology
Fellowship Training in Transfusion Medicine
Bloodworks Academy
Contact Us
Contact Us
Donate
What Can I Donate?
Whole Blood
Double Red Cell
Plasma
Platelets
Cord Blood
Funding for our Mission
What Do I Need to Know?
Frequently Asked Questions
Eligibility
Identification Requirements
Special Considerations
What Happens to My Blood?
Ways to Donate
Schedule Online
Donor Center Locations
Mobile Blood Drives
Mobile Apheresis Donation
Organize a Blood Drive
Email & Text Reminders
Financial Donations
Volunteer Opportunities
Products & Services
Products & Services
Blood Components
Ordering Blood Components
Online Reports/Status
Handling Storage and Returns
Apheresis and Cellular Therapies
Laboratory Testing
Cord Blood
Biological Products for Research
Transfusion Services
Transfusion Medicine
Transfusion Guide: Blood Components
Transfusion Safety/Administration
Online Reports/Status
Perinatal Testing
WA Center for Bleeding Disorders
WA Center for Bleeding Disorders Overview
For Physicians
Hospital Pharmacy – Factor Ordering
Customer Service
Patients
Patient Services
Patient Services Overview
Therapeutic Phlebotomy
Patient Services Physicians
Bleeding Disorders
WA Center for Bleeding Disorders
What Are Bleeding Disorders
For Patients
Ordering Factor
Transfusions
When You Need a Transfusion
Customer Service
Labs
Labs
Compatibility Testing Laboratory
Donor Testing-Quality Control Laboratory
Genomics Testing Laboratory
Hemostasis Reference Laboratory
Immunogenetics/HLA Laboratory
Platelet Immunology Laboratory
Immunohematology Reference Laboratory (IRL)
Lab Services
Clinical Trials & Contract Testing
Physician Consulting
Blood Components
Frequently Asked Questions
Lab Contacts
Lab Tests
Lab Test Index
Online Reports/Status
Research
Bloodworks Research Institute
Research Overview
Life Saving Discoveries
Now and in the Future
Strategic Plan
FCOI Compliance
Biological Products
Center for Global Impact
Core Facilities and Technologies
Core Overview
Biostatistics Core
Flow Cytometry Lab
Mass Spectrometry Lab
Researchers
Meet Our Researchers
Jing-Fei Dong M.D., Ph.D.
Xiaoyun Fu, Ph.D.
Dominic Chung Ph.D.
Krystalyn E Hudson, Ph.D.
Jill M. Johnsen, M.D.
Barbara A. Konkle, M.D.
José López, M.D.
Karen Nelson, Ph.D. D (ABHI)
Sherrill Slichter, M.D.
Paul Warner, Ph.D.
James Zimring, M.D., Ph.D.
About Us
Who We Are
About Us
Leadership Team
Board of Trustees
Careers
Licenses and Accreditations
Medical staff
James AuBuchon, M.D.
Meghan Delaney, D.O., M.P.H.
Rebecca Haley, M.D.
Barbara Konkle, M.D.
Theresa A. Nester, M.D.
Yanyun Wu, M.D.
Kirsten Alcorn, M.D.
Rebecca Kruse-Jarres, MD, MPH
Our Impact
Lives Saved
Awards and Recognitions
2016 Community Report
News & Community Events
Center for Global Impact | Bloodpak
Education & Training
Introduction to Hematology
Fellowship Training in Transfusion Medicine
Bloodworks Academy
Contact Us
Contact Us
Lab Test Index
Tests performed at Bloodworks Northwest
%, 1-9
% ABO for HSCT
22 inversion (see
DNA Factor VIII Inversion
)
A
A1 lectin (see
Group A Subgroup Typing
)
A1 subgroup (see
Group A Subgroup Typing
)
ABO & Rh (D antigen typing)
ABO Compatible Crossmatch
ABO Genotyping
ABO Incompatible Heart Transplant Titer (anti A or anti B)
ABO Incompatible Liver Transplant Titer (anti A or anti B)
ABO/Rh
ABO-Rh by Automated Methodology
ABO-Rh by Gel Methodology
ADAMTS 13 Activity
ADAMTS 13 Antibody
ADAMTS 13 Inhibitor
(test performed if activity level <30%)
Alloadsorption
Allogenic Adsorption (see
Alloadsorption
)
Anti A Titer for HSCT
Anti-A Titer for Kidney Transplant (see
UNOS Protocol Titer (anti-A)
)
Anti B Titer for HSCT
Antibody Identification
Anti-AT1R Antibody
Antibody Screen (see
Blood Donor, Red Cell Antibody Screen – Pooled Cells
)
Antibody Titer (other than anti A or anti B)
Anticoagulation monitoring (see
Apixaban – Direct Thrombin Inhibitor
,
Dabigatran – Direct Thrombin Inhibitor
or
RIPA
)
Anti-CMV (see
Cytomegalovirus Total Antibody
)
Anti-HBc (see
Hepatitis B Core Antibody
)
Anti-HCV (see
Hepatitis C Antibody
)
Anti-HCV (alternate)
Anti-HIV-1/HIV-2 (see
HIV-1/HIV-2/group O Antibody
)
Anti-HTLV-I/II (see
HTLV-I/II Antibody
)
Anti-HTLV-I/II Confirmatory (see
HTLV-I/II Confirmation Panel
)
Antiplasmin
Anti-Trypanosoma cruzi (see
Trypanosoma cruzi Antibody
)
Apixaban Level
APTT (Abnormals reflex to 1:1 mix)
APTT (Post-Heparin Removal)
APTT 1:1 Mix
APTT 1:1 Mix (incubated)
Aspirin Resistance Aggregation
ATS-13 (see
ADAMTS 13 Activity
)
ATS-13 antibody (see
ADAMTS 13 Antibody
)
ATS-13 inhibitor (see
ADAMTS 13 Inhibitor
)
Autoadsorption
Autologous Adsorption (see
autoadsorption
)
B
Blood Donor, Red Cell Antibody Screen – Pooled Cells
C
Chagas (see
Trypanosoma cruzi Antibody
)
Chagas Confirmatory (see
Trypanosoma cruzi Confirmation
)
CMV (see
Cytomegalovirus Total Antibody
)
CMV-total (see
Cytomegalovirus Total Antibody
)
Clopidogrel/Prasagril Resistance Panel
Complement-fixing HLA Antibody Monitoring DSA
Complement-fixing HLA Antibody Monitoring DSA-STAT
Complement-fixing HLA Antibody Specificity
Crossmatch AHG
Crossmatch Electronic
Crossmatch-Immediate Spin
Cytomegalovirus Total Antibody
D
D,C,E,c and e antigen typing, complete (see
Rh Phenotype (D,C,E,C Antigen typing)
)
D,C,E,c, e and K antigen typing (see
Sickle Cell Phenotype (Rh & K)
)
Dabigatran Level
D-Dimer (Quantitative)
Dilute russell viper venom (see
dRVVT Confirm Ratio
or
dRVVT Screen
(reflexes to
dRVVT Confirm Ratio
))
Direct Antiglobulin Test-Immunohematology Reference Lab
Direct Antiglobulin Test-Transfusion Service Customers
DNA Factor II (prothrombin) Mutation
DNA Factor V Leiden (APC Resistance) Mutation
DNA Factor VIII Inversion
DNA Hemophilia A Mutation Screen
DNA Hemophilia B Mutation Screen
DNA von Willebrand Disease Type 2A/2B/2M
DNA von Willebrand Disease Type 2N
Donath-Landsteiner Test for PCH
Donor Phenotype (C,c,E,e,K) (see
Red Cell Antigen Phenotype
)
Donor Phenotype: Rh + Kell (see
Red Cell Antigen Phenotype
)
Drug induced thrombocytopenia (see
Platelet Drug Antibody Test
)
dRVVT Confirm Ratio
dRVVT Screen
(reflexes to
dRVVT Confirm Ratio
)
E
EBVC (see
EBV Viral Capsid IgG
)
EBVN (see
EBV Nuclear Antigen IgG
)
EBV-NA-IgG (see
EBV Nuclear Antigen IgG
)
EBV-VCA-IgG (see
EBV Viral Capsid IgG
)
EBV Nuclear Antigen IgG
EBV Viral Capsid IgG
Elution
Extended Patient Phenotype (7 or more antigens)
F
F8 genotyping (see
DNA Hemophilia A Mutation Screen
)
F9 genotyping (see
DNA Hemophilia B Mutation Screen
)
Factor Inhibitors (IX,II,V,VII,X,XI)
Factor II Activity
Factor II genotyping (see
DNA Factor II (prothrombin) Mutation
)
Factor IX Activity
Factor V Activity
Factor VII Activity
Factor VIII Activity
Factor VIII Activity Chromogenic
Factor VIII Inhibitor by Bethesda Titer – Human
Factor VIII Inhibitor by Bethesda Titer – Porcine
Factor X Activity
Factor XI Activity
Factor XII Activity
Factor XIII Screen
FDP In Plasma (Semi-Quantitative)
Fibrinogen Activity
FV Leiden genotyping (see
DNA Factor V Leiden (APC Resistance) Mutation
)
G
Genotype for known Hemophilia / VWD mutation
Group A Subgroup Typing
H
HBsAg (see
Hepatitis B Surface Antigen
)
HBsAg Confirmatory (see
HBsAg Neutralization
)
HBsAg Neutralization
HBV-DNA (see
HCV/HIV/HBV/ NAT Multiplex
)
HBV-NAT (see
HCV/HIV/HBV/ NAT Multiplex
)
HBcAb (see
Hepatitis B Core Antibody
)
HCV (see
Hepatitis C Antibody
)
HCV/HIV/HBV-NAT (see
HCV/HIV/HBV/ NAT Multiplex
)
HCV/HIV/HBV Multiplex NAT
HCV-NAT (see
HCV/HIV/HBV/ NAT Multiplex
)
HCV-RNA (see
HCV/HIV/HBV/ NAT Multiplex
)
HemA genotyping (see
DNA Hemophilia A Mutation Screen
)
HemB genotyping (see
DNA Hemophilia B Mutation Screen
)
Hemolysis Evaluation
Hemophilia carrier testing (see
Genotype for known Hemophilia / VWD mutation
)
Heparin Antibody Test-Platelet Factor 4 ELISA (IgG, IgA and IgM)
Heparin/PF4 IgG ELISA
Heparin/PF4 IgG ELISA Confirmation
Hepatitis B Core Antibody
Hepatitis B Surface Antigen
Hepatitis C Antibody
High Resolution Typing HLA-A
High Resolution Typing HLA-B
High Resolution Typing HLA-C
High Resolution Typing HLA-DPA1
High Resolution Typing HLA-DPB1
High Resolution Typing HLA-DQA1
High Resolution Typing HLA-DQB1
High Resolution Typing HLA-DRB1
High Resolution Typing HLA-DRB3/DRB4/DRB5
HIT (see
Heparin Antibody Test-Platelet Factor 4 ELISA (IgG, IgA and IgM)
or
Heparin/PF4 IgG ELISA
or
Heparin/PF4 IgG ELISA Confirmation
)
HIV 1/2 Confirmatory
HIV-1/HIV-2/group O Antibody
HIV-NAT (see
HCV/HIV/HBV/ NAT Multiplex
)
HIV-RNA (see
HCV/HIV/HBV/ NAT Multiplex
)
HLA Antibody Detection
HLA Antibody Specificity
HLA Antibody Specificity-Monitoring (DSA Donor-Specific Antibody)
HLA Antibody Specificity-Monitoring (DSA Donor-Specific Antibody)-STAT
HLA Class I (A,B,C) Typing
HLA Class I+II (A, B, C, DR, DQ) Typing
HLA Class II (DR, DQ) Typing
HLA-A2 or A*02:01 (A*0201)Typing
HLA-A*29 Typing (Birdshot Retinopathy association)
HLA-B*15:02 (B1502, B75)Typing
HLA-B*27 Typing (Ankylosing Spondylitis, other arthropathies)
HLA-B*51 (B51,B5) Typing (Behcet’s Disease association)
HLA-B*57:01 (B*5701) Typing (Abacavir hypersensitivity)
HLA-B*58:01 (B*5801) Typing
HLA-DQ2/DQ8/DQA1*05 (Celiac association)
HLA-DQB1*06:02 (DQB1 *0602) Typing (Narcolepsy association)
HPA Genotyping (extended typing)
HTLV-I/II Antibody
HTLV-I/II Confirmation Panel
Hold Sample
I
INR (see
Prothrombin Time (Abnormals reflex to 1:1 mix)
)
Indirect Antiglobulin Test (antibody Screen)
Intron 1 or 22 inversion (see
DNA Factor VIII Inversion
)
Irregular Antibody Screen (see
Red Cell Antibody Screen – Pooled
)
L
Lectin Panel (T activation of RBCs)
Long term marrow transplant (HSCT) recipient follow up
Lupus anticoagulant (see
dRVVT Confirm Ratio
or
dRVVT Screen
)
Lymphocyte Crossmatch
Lymphocyte Crossmatch (Stat)
Lymphocyte Crossmatch – Cytotoxicity only
M
MICA antibody
MICA typing
MNS genotyping (see
Red Cell Genotyping for MNS Blood systems
)
Multiplex NAT ( see
HCV/HIV/HBV Multiplex NAT
)
N
NAIT (see
Neonatal Alloimmune Thrombocytopenia Evaluation
)
NAT by PCR (see
HCV/HIV/HBV/ NAT Multiplex
)
NATP (see
Neonatal Alloimmune Thrombocytopenia Evaluation
)
Neonatal Alloimmune Thrombocytopenia Evaluation
P
PT (see
Prothrombin Time (Abnormals reflex to 1:1 mix)
)
PTP (see
Post Transfusion Purpura (PTP) Workup
)
PTT (see
APTT (Abnormals reflex to 1:1 mix)
or
APTT (Post-Heparin Removal)
)
Percent ABO (see
% ABO for HSCT
)
Platelet Aggregation
Platelet Alloantibody Workup – Advanced
Platelet Alloantibody Workup – Basic
Platelet Autoantibody Test (ITP Workup)
Platelet Drug Antibody Test
Platelet flow cytometry (see
Platelet Autoantibody Test (ITP Workup)
)
Platelet Function Assay (PFA) ADP/Collagen
Platelet Function Assay (PFA) Epinephrine/Collagen
Platelet refractory antibody (see
Platelet Alloantibody Workup – Basic
)
Platelet specific antibody (see
Platelet Alloantibody Workup – Advanced
)
Platelet Typing for Single Platelet Antigen
Plavix monitoring (see
Clopidogrel/Prasagril Resistance Panel
)
Post Transfusion Purpura (PTP) Workup
Prenatal Antibody Identification (includes antibody titration, if indicated)
Prothrombin Time (Abnormals reflex to 1:1 mix)
Prothrombin Time 1:1 Mix
R
Red Cell Antibody Screen (IRL)
Red Cell Antibody Titration (see
Antibody Titer (other than anti A or anti B)
)
Red Cell Antigen Phenotype
Red Cell Antigen Typing Other Than Rh Antigens (see
Extended Patient Phenotype (7 or more antigens))
Red Cell Genotyping for MNS Blood systems
Red Cell Genotyping for multiple blood groups
Red Cell Genotyping for Single Blood Group (per antigen system)
Red Cell Genotyping-common antigens (Kell, Kidd, Duffy, Ss)
Reptilase Time
Resolution of ABO discrepancy
Rh Genotyping – Rh C,D,E Systems
Rh Phenotype (D,C,E,c and e Antigen typing)
RhD Evaluation (weak or partial D eval)
RhD variant – weak D types 1,2,3
RhD zygosity (including CDE systems)
RIPA (Ristocetin Induced Platelet Aggregation)
Ristocetin induced platelet aggregation (see
RIPA
)
Rivaroxaban Level
RPR (see
Syphilis Test by RPR
)
S
Screening of antigen-Negative RBC units
Screening of compatible RBC units
Sickle Cell Phenotype (Rh & K)
Single Antigen Phenotype
Solid Organ Donor ABO & Rh (A1 lectin if group A) RF11
Specimen Processing/Storage (Lymphocytes)
Specimen Processing/Storage (Serum)
STACLOT-LA (Hexagonal Pl)
STS (see
Syphilis Test by PK-TP
or
Syphilis Test by RPR
)
Suspected Hemolytic Transfusion Reaction Evaluation
Suspected delayed Transfusion Reaction
SYP-G (see
Treponema pallidum Antibody
)
Syphilis IgG (see
Treponema pallidum Antibody
)
Syphilis Test by PK-TP
Syphilis Test by RPR
T
Thermal Amplitude
Thrombin Time (Abnormals reflex to 1:1 mix)
Thrombin Time 1:1 Mix
Toxo (see
Toxoplasma IgG Antibody
)
Toxoplasma-IgG (see
Toxoplasma IgG Antibody
)
Toxoplasma IgG Antibody
TP (see
Syphilis Test by PK-TP
)
Treponema pallidum Antibody
Trypanosoma cruzi Antibody
Trypanosoma cruzi Confirmation
U
UNOS Protocol Titer (anti A)
V
VWD genotyping (see
DNA von Willebrand Disease Type 2A/2B/2M
or
DNA von Willebrand Disease Type 2N
)
VWF Activity by Ristocetin Cofactor
VWF Antigen
VWF Collagen Binding
VWF Multimers
W
WNV-NAT (see
West Nile Virus Nucleic Acid Test
)
WNV-RNA (see
West Nile Virus Nucleic Acid Test
)
West Nile Virus Nucleic Acid Test
X
Xarelto (see
Rivaroxaban – Direct Thrombin Inhibitor
)
Your gift of blood, time or money saves lives.
DONATE AND MAKE AN IMPACT